NIPH Clinical Trials Search

The Hokuriku-plus Acute Coronary Syndrome Registry Study

Basic Information

Recruitment status	Recruiting
Health condition(s) or Problem(s) studied	Acute coronary syndrome
Date of first enrollment	29/10/2025
Target sample size	1000
Countries of recruitment
Study type	Interventional
Intervention(s)	Implement LDL cholesterol management using a standardized clinical pathway and conduct familial hypercholesterolemia screening, considering genetic testing as needed.

Outcome(s)

Primary Outcome	Achievement of LDL cholesterol management target (<55 mg/dL) at 4 weeks.
Secondary Outcome	Achievement of LDL cholesterol management target (< 55 mg/dL) at 12 weeks and 52 weeks. Achievement of LDL cholesterol management target (< 70 mg/dL) at 4 weeks, 12 weeks, and 52 weeks. Presence/absence of familial hypercholesterolemia diagnosis at 52 weeks. Cardiac events, safety (adverse events).

Key inclusion & exclusion criteria

Age minimum	>= 18age old
Age maximum	Not applicable
Gender	Both
Include criteria	1) Patients hospitalized for acute coronary syndrome 2) Age 18 years or older 3) Written informed consent obtained from the patient voluntarily after providing sufficient informed consent regarding participation in this clinical study
Exclude criteria	1) Patients who find it difficult to attend regular outpatient appointments 2) Patients who are pregnant or breastfeeding 3) Other patients deemed unsuitable for the program at the physician's discretion